These studies illustrate the complex nature of Eph-Ephrin signaling during prostate cancer growth and progression and emphasize the need to better understand how this pathway coordinates tumor–stroma interactions, which could reveal new therapeutic avenues and/or biomarkers. The gene discussed is EPHA1; the disease is neoplasm.